ArticleJournal of inflammation research2025
Predictors of Abdominal Pain Duration in Henoch-Schönlein Purpura and Nomogram Model Development: A Retrospective Study of 220 Cases.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Our study aims to identify risk factors that predict an abnormally prolonged duration of abdominal pain relief (DAPR) in patients with abdominal Henoch-Schönlein purpura (A-HSP) and to construct a nomogram for early prediction. Methods: We reviewed data of all patients (n = 375) with confirmed A-HSP from the Chongqing Medical University platform, from 22 January 2011 to 18 November 2022. After applying rigorous inclusion and exclusion criteria, 220 patients were ultimately enrolled. We split them into two groups by the DAPR: < 1 week and ≥ 1 week. Multivariate relogit regression was performed to select factors associated with DAPR lasting ≥ 1 week, including demographics, symptoms, laboratory results, and treatment. We then constructed a nomogram to estimate risk probability and internally validated its performance via bootstrapping using discrimination, calibration, and clinical utility. Results: There were 220 patients in the training. Multivariate relogit regression analysis demonstrated that age, initial onset, neutrophil-to-lymphocyte ratio (NLR), and bowel wall thickening were independent risk factors for DAPR ≥ 1 week. The Area Under the Curve (AUC) of the nomogram constructed based on the above factors was 0.849. Both the Calibration curve and Decision Curve Analysis (DCA) of the nomogram showed that the model exhibited good fitness. Conclusion: The nomogram can effectively predict the prolonged duration of abdominal pain (≥ 1 week) in A-HSP patients, helping clinicians distinguish high-risk patients at an early stage and optimize treatment plans. However, external validation remains essential before clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.